An all-island, international event in Dublin Castle on March 4 that explores the future for globally networked biopharmaceutical innovation. #BioAmbition20
Our Interim CEO Rob Grundy addresses the BioPharma Ambition Conference in Dublin highlighting the work HIRANI is engaged in across the island of Ireland to drive prosperity and health outcomes through collaboration. #BioAmbition20
This afternoon, Shane Gannon, Director in our Pharmaceuticals and Life Science Consulting practice, chaired the “Future-fitting biopharma for best societal impact” session at the @BioAmbition Conference #BioAmbition20
In the North, HIRANI is strengthening links between universities, healthcare providers and industry to drive growth in the life sciences sector, says Dr Robert Grundy of @4healthalliance at BioPharma Ambition 2020. @PwCIreland@McKesson#BioAmbition20
The future for the biopharmaceutical sector is collaboration, says Gary Hartnett of @JanssenIE, at BioPharma Ambition 2020. We must focus on speeding access to new medicines, enhancing the clinical trials landscape and developing skills. #BioAmbition20
Biopharmaceuticals makes a huge contribution to Europe’s economy, with €206bn in GVA, 2.5m jobs and 46% of direct employment accounted for by women, says Shane Gannon of @PwCIreland at BioPharma Ambition 2020. @IDAIreland@Entirl @scienceirel @Inter_Trade#BioAmbition20
The future for biopharmaceuticals in Ireland should not be a binary choice between continuous improvement in small and large-molecule medicines and the development of ATMPs. The opportunity is in both, says Shane Gannon of @PwCIreland at BioPharma Ambition 2020 #BioAmbition20
Great talk from Ruth Beadle of @sanofi on the lessons they have learned from their journey with digital health and technology. Ruth travelled around Ireland learning about different companies and universities approach to digital health. Very patient focussed talk! #BioAmbition20
Quicker product launches, agile decision-making and competitiveness are key to the future of Ireland’s biopharmaceutical industry, says Sanofi’s Ruth Beadle at BioPharma Ambition 2020. @BioPharmChemIre@ipha@NIBRT_#BioAmbition20